Beech Hill Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Beech Hill Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$801K	Sell	5,082 -50	-1%	-$7.89K	0.36%	72
2026 Q2	$812K	Sell	5,132 -28	-0.5%	-$3.78K	0.36%	72
2026 Q1	$659K	Sell	5,160 -235	-4%	-$29.3K	0.33%	71
2025 Q4	$658K	Sell	5,395 -360	-6%	-$41.3K	0.31%	71
2025 Q3	$577K	Sell	5,755 -496	-8%	-$44.7K	0.27%	75
2025 Q2	$518K	Sell	6,251 -389	-6%	-$31K	0.23%	78
2025 Q1	$539K	Sell	6,640 -15	-0.2%	-$1.34K	0.21%	80
2024 Q4	$599K	Buy	6,655 +162	+2%	+$15.7K	0.22%	78
2024 Q3	$642K	Buy	6,493 +60	+0.9%	+$5.9K	0.24%	75
2024 Q2	$596K	Sell	6,433 -35	-0.5%	-$3.14K	0.25%	74
2024 Q1	$614K	Buy	6,468 +1,616	+33%	+$150K	0.26%	69
2023 Q4	$433K	Buy	+4,852	New	+$360K	0.21%	75

Other funds holding XBI

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Williams Jones Wealth Management New York $8.94B AUM 17.99% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

Beech Hill Advisors's XBI Position: Q3 2026 in Review

Beech Hill Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.97% in Q3 2026, selling an estimated $7.89K and leaving 5,082 shares worth $801K. The position accounts for 0.36% of the portfolio, ranked #72.

Beech Hill Advisors first reported a position in XBI in Q4 2023 and has held it in 12 quarters since. The position peaked at $812K in Q2 2026. 521 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Beech Hill Advisors held 5,082 shares of State Street SPDR S&P Biotech ETF worth $801K as of Q3 2026.
Beech Hill Advisors sold 50 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $7.89K.
State Street SPDR S&P Biotech ETF made up 0.36% of Beech Hill Advisors's portfolio in Q3 2026, its #72 holding.
Beech Hill Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 12 quarters since.
Beech Hill Advisors's State Street SPDR S&P Biotech ETF position peaked at $812K in Q2 2026.
521 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Beech Hill Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.